Stay updated on Semaglutide Dose Response Study in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Semaglutide Dose Response Study in Type 2 Diabetes Clinical Trial page.

Latest updates to the Semaglutide Dose Response Study in Type 2 Diabetes Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRecruitment status updated to indicate no longer looking for participants, signaling enrollment has completed. A new record revision (v3.6.0) was added and a previous revision (v3.5.5) was removed, reflecting versioning in the study history.SummaryDifference0.4%

- Check20 days agoChange DetectedNew history entry v3.5.5 was added to the page. The previous entry v3.5.4 was removed, reflecting a minor update to the page's version history.SummaryDifference0.1%

- Check42 days agoChange DetectedThe Record History now shows a new revision entry labeled v3.5.4, replacing the previous v3.5.3. This reflects an update to the study record on ClinicalTrials.gov.SummaryDifference0.1%

- Check63 days agoChange DetectedUpdated the website interface revision label from v3.5.2 to v3.5.3 on the record history page.SummaryDifference0.1%

- Check70 days agoChange DetectedAdded revision entry v3.5.2 and removed revision v3.5.0 in the study history.SummaryDifference0.1%

- Check99 days agoChange DetectedRevision: v3.5.0 was added to the record history and Revision: v3.4.3 was removed.SummaryDifference0.2%

Stay in the know with updates to Semaglutide Dose Response Study in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide Dose Response Study in Type 2 Diabetes Clinical Trial page.